Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.7%

13 terminated/withdrawn out of 169 trials

Success Rate

88.8%

+2.3% vs industry average

Late-Stage Pipeline

46%

78 trials in Phase 3/4

Results Transparency

18%

19 of 103 completed trials have results

Key Signals

28 recruiting19 with results8 terminated5 withdrawn

Enrollment Performance

Analytics

Phase 3
52(36.9%)
N/A
51(36.2%)
Phase 4
26(18.4%)
Phase 2
9(6.4%)
Early Phase 1
2(1.4%)
Phase 1
1(0.7%)
141Total
Phase 3(52)
N/A(51)
Phase 4(26)
Phase 2(9)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (169)

Showing 20 of 169 trials
NCT02840201Completed

Sub-Clinical Atrial Fibrillation Biomarker Study

Role: collaborator

NCT06188689Not ApplicableRecruiting

Evaluation of A Clinical Diagnostic Test for CRDS

Role: lead

NCT06337838Phase 3Recruiting

Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial

Role: collaborator

NCT07511543Phase 2Not Yet Recruiting

Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy

Role: lead

NCT07300579Not Yet Recruiting

Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2

Role: collaborator

NCT05478304Not ApplicableActive Not Recruiting

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Role: collaborator

NCT04774159Phase 3Recruiting

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Role: lead

NCT05963698Not ApplicableRecruiting

The Fourth Left Atrial Appendage Occlusion Study

Role: collaborator

NCT06174220Phase 2Recruiting

Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy

Role: collaborator

NCT07468448Phase 3Not Yet Recruiting

Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in IntraCranial Atherosclerotic diseaSe (CATIS- ICAS)

Role: lead

NCT03950076Phase 4Active Not Recruiting

EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)

Role: lead

NCT06587737Phase 3Not Yet Recruiting

Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage

Role: lead

NCT05531474Not ApplicableRecruiting

Bariatric Surgery for the Reduction of cArdioVascular Events Randomized Controlled Trial

Role: lead

NCT07367633Not ApplicableNot Yet Recruiting

Head of Bed After Ischemic Stroke Thrombectomy (HoBIT)

Role: lead

NCT06508164Recruiting

International CRDS Registry

Role: lead

NCT03968393Phase 4Recruiting

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

Role: lead

NCT03636295Phase 3Recruiting

Low INR to Minimize Bleeding With Mechanical Valves Trial

Role: lead

NCT06648239Not ApplicableActive Not Recruiting

CCTA to Optimize Diagnostic Yield of Invasive Angiography With AI

Role: collaborator

NCT04743765Not ApplicableRecruiting

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

Role: lead

NCT04284839Phase 3Recruiting

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Role: lead